Sign in

CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
113516358
Phone
(984) 884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
  1. DEFA14A Proxy Proxy Materials
  2. PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
  3. DEFA14A Proxy Proxy Materials
  4. EFFECT Other Notice of Effectiveness
  5. DEFA14A Proxy Proxy Materials
  6. DFAN14A Other Proxy Soliciting Materials
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. S-3/A Offering Registration Statement
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. DEFA14A Proxy Proxy Materials
  12. 8-K Event Agreement ended
  13. 424B5 Offering Prospectus
  14. PRRN14A Other PRRN14A
  15. DEFC14A Other DEFC14A
  16. DFAN14A Other Proxy Soliciting Materials
  17. 10-K Report Annual Report
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. PRER14A Other PRER14A
  20. 8-K Event Results of operations

Page 9 of 54 · 1,070 filings